Characterization of Differences Between Prostate Cancer Patients Presenting With De Novo Versus Primary Progressive Metastatic Disease.

Finianos, Antoine; Gupta, Kanika; Clark, Brandon; Simmens, Samuel J; Aragon-Ching, Jeanny B

Finianos, Antoine; Gupta, Kanika; Clark, Brandon; Simmens, Samuel J; Aragon-Ching, Jeanny B.

Afiliação

Finianos A; Division of Hematology and Oncology, The George Washington University School of Medicine and Health Sciences, Washington, DC.
Gupta K; Division of Hematology and Oncology, The George Washington University School of Medicine and Health Sciences, Washington, DC.
Clark B; Department of Epidemiology and Biostatistics, The George Washington University Milken Institute School of Public Health, Washington, DC.
Simmens SJ; Department of Epidemiology and Biostatistics, The George Washington University Milken Institute School of Public Health, Washington, DC.
Aragon-Ching JB; GU Medical Oncology, Inova Schar Cancer Institute, Fairfax, VA. Electronic address: Jeanny.Aragon-Ching@inova.org.

Clin Genitourin Cancer ; 2017 Aug 31.

Article em En | MEDLINE | ID: mdl-28899723

Palavras-chave

Castration resistance; De novo metastatic disease; Metastatic prostate cancer; Prostate specific antigen; Treatment

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Clin Genitourin Cancer Assunto da revista: NEOPLASIAS / UROLOGIA Ano de publicação: 2017 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google